Enter a Ticker Symbol To Get Your Free Bull/Bear Rating & Ranking Report from "Stock Scientist" Mike Turner

Dividend Quote

ABEO

Abeona Therapeutics Inc

Add to Scorecard

New Report from the Award-winning Analyst Who Beat the Market Over 15 Years

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.

ABEO:Abeona Therapeutics Inc - Stock Quote and Dividend Data

LATEST CLOSE PRICE

$7.36

EXCHANGE

NASDAQ

SECTOR

Health Care

ABEO
Abeona Therapeutics Inc Dividend Information
Trailing 12 Month Dividend Yield0.00%
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years

Dividend Payment TypeNone
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone

FREE INVESTOR BRIEFING

Collect an 8% Yield on this "Government Mandated Income Opportunity"

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.
ABEO
Abeona Therapeutics Inc Stock Information
Latest Close Price$7.36
52-Week Low/High$6.94 - $22.00
Percent Held by Institutions0.00%
Revenue$7,050,000
Net Income$-61,451,000
Cash Flow$-9,040,000
EPS-0.34%
Market Cap$353,107,560
PE Ratio0
PE Ratio to Industry62%
Debt-Equity Ratio0.00%
Debt-Equity to Industry1.39%
Total Return Last 12 Months-54.25%
Total Return Last 3 Years115.35%
Total Return Last 5 Years-44.50%
Latest Trade DateDec. 14, 2018
ABEO
Abeona Therapeutics Inc Dividend Payment History

No Data available for Payment History.

ABEO
Abeona Therapeutics Inc Other Details

Abeona Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening rare genetic diseases. Co.'s main programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). Co. is also developing ABO-201 (AAV-CLN3) gene therapy for juvenile Batten disease (JNCL), and ABO-202 (AAV-CLN1) for treatment of infantile Batten disease (INCL), among others.

Web Sitewww.abeonatherapeutics.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Try Dividend Investor PREMIUM for as low as $29

  • Dividend Allstars™ Tool
  • Proprietary Ex-dividend Calendar
  • Dividend Scorecard™ Portfolio Tracker
  • Customized Dividend Stock Screener
  • 4 FREE special reports from leading dividend experts
  • And much more...
 
Abeona Therapeutics Inc Dividend Stock News and Updates

Dec. 12, 2018CLOSE PRICE DECREASE: Abeona Therapeutics Inc (NASDAQ: ABEO) on 12-12-2018 decreased close price > 10% from $9.01 to $7.97

Read more...

Dec. 05, 2018CLOSE PRICE DECREASE: Abeona Therapeutics Inc (NASDAQ: ABEO) on 12-05-2018 decreased close price > 10% from $8.50 to $7.59

Read more...

Nov. 13, 2018CLOSE PRICE DECREASE: Abeona Therapeutics Inc (NASDAQ: ABEO) on 11-13-2018 decreased close price > 10% from $9.36 to $7.71

Read more...
More Abeona Therapeutics Inc Dividend News
Biotechnology Dividend Stock News and Updates

Dec. 15, 2018CLOSE PRICE DECREASE: Advaxis Inc (NASDAQ: ADXS) on 12-15-2018 decreased close price > 10% from $0.38 to $0.24

Read more...

Dec. 15, 2018CLOSE PRICE DECREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 12-15-2018 decreased close price > 10% from $0.05 to $0.03

Read more...

Dec. 15, 2018CLOSE PRICE INCREASE: AVAX Technologies, Inc. (OTCBB: AVXT) on 12-15-2018 increased close price > 10% from $0.00 to $0.00

Read more...
More Biotechnology Dividend News
FREE REPORT
X
Bryan Perry Dividend Income Expert Bryan Perry

Earn 8% on this "Government Mandated Income Opportunity"

X

Search Dividend Investor